Development of Therapeutic Monoclonal Antibodies for Emerging Arbovirus Infections
Open Access
Abstract
Antibody-based passive immunotherapy has been used effectively in the treatment and prophylaxis of infectious diseases. Outbreaks of emerging viral infections from arthropod-borne viruses (arboviruses) represent a global public health problem due to their rapid spread, urging measures and the treatment of infected individuals to combat them. Preparedness in advances in developing antivirals and relevant epidemiological studies protect us from damage and losses. Immunotherapy based on monoclonal antibodies (mAbs) has been shown to be very specific in combating infectious diseases and various other illnesses. Recent advances in mAb discovery techniques have allowed the development and approval of a wide number of therapeutic mAbs. This review focuses on the technological approaches available to select neutralizing mAbs for emerging arbovirus infections and the next-generation strategies to obtain highly effective and potent mAbs. The characteristics of mAbs developed as prophylactic and therapeutic antiviral agents for dengue, Zika, chikungunya, West Nile and tick-borne encephalitis virus are presented, as well as the protective effect demonstrated in animal model studies.Keywords
All Related Versions
Funding Information
- Coordination for the Improvement of Higher Education Personnel (CAPES) (2020/15833-1)
- Sao Paulo Research Foundation (FAPESP) (2020/15833-1)
This publication has 160 references indexed in Scilit:
- Beyond natural antibodies: the power of in vitro display technologiesNature Biotechnology, 2011
- Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354Proceedings of the National Academy of Sciences, 2010
- Generation of stable monoclonal antibody–producing B cell receptor–positive human memory B cells by genetic programmingNature Medicine, 2009
- Development of Resistance to Passive Therapy with a Potently Neutralizing Humanized Monoclonal Antibody against West Nile VirusThe Journal of Infectious Diseases, 2009
- High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodiesJournal of Virological Methods, 2009
- The structural immunology of antibody protection against West Nile virusImmunological Reviews, 2008
- DengueThe Lancet, 2007
- An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirusNature Medicine, 2004
- Phage antibodies: filamentous phage displaying antibody variable domainsNature, 1990
- Replacing the complementarity-determining regions in a human antibody with those from a mouseNature, 1986